Target intelligence / Profile preview

Ileal sodium/bile acid cotransporter (ASBT)

Target
ASBT
Molecular classification
Transporter, Symporter, Solute carrier family
01

Overview

The ileal sodium/bile acid cotransporter, commonly known as the apical sodium-dependent bile acid transporter (ASBT) or ileal bile acid transporter (IBAT), is a transmembrane protein primarily expressed on the apical membrane of enterocytes in the terminal ileum. It plays a critical role in the enterohepatic circulation of bile acids by actively reabsorbing conjugated and unconjugated bile acids from the intestinal lumen in a sodium-dependent manner. This reabsorption process is essential for maintaining bile acid and cholesterol homeostasis. Dysregulation or genetic mutations in this transporter can lead to primary bile acid malabsorption, characterized by chronic diarrhea and steatorrhea.

In pharmacological contexts, this transporter is a highly attractive therapeutic target. Inhibiting its activity prevents the reabsorption of bile acids, promoting their excretion in feces and reducing systemic bile acid levels. This mechanism is utilized by approved drugs to treat severe cholestatic pruritus in rare genetic liver disorders like Alagille syndrome and progressive familial intrahepatic cholestasis (PFIC), as well as primary biliary cholangitis (PBC). Additionally, inhibitors of this transporter are used to treat chronic constipation. Safety concerns associated with its inhibition include gastrointestinal side effects such as diarrhea and abdominal pain, potential hepatotoxicity, and deficiencies in fat-soluble vitamins (A, D, E, and K) which can lead to bleeding complications.

Other names
Apical sodium-dependent bile acid transporterIleal bile acid transporterIleal sodium-dependent bile acid transporterSolute carrier family 10 member 2Na(+)-dependent ileal bile acid transporterSodium/taurocholate cotransporting polypeptide, ilealASBTIBATISBTNTCP2PBAM
02

Mechanism of action

Inhibition of the apical sodium-dependent bile acid transporter (ASBT/IBAT) to block the reabsorption of bile acids in the terminal ileum, thereby reducing systemic bile acid levels and promoting fecal excretion.

03

Biological functions

Bile acid transportSodium transportCholesterol metabolismEnterohepatic circulationIon transport
04

Disease associations

CholestasisPruritusAlagille syndromeProgressive familial intrahepatic cholestasisPrimary biliary cholangitisPrimary sclerosing cholangitisConstipationBile acid malabsorptionHypertriglyceridemia
05

Safety considerations

DiarrheaAbdominal painHepatotoxicity (elevated liver enzymes)Fat-soluble vitamin deficiency (Vitamins A, D, E, K)Bleeding risk (secondary to Vitamin K deficiency)Gastrointestinal discomfort
06

Interacting drugs

5 more in the full profile.

07

Biomarkers

Serum bile acidsFecal bile acids7alpha-hydroxy-4-cholesten-3-one (C4)Fibroblast growth factor 19 (FGF19)

Beyond the preview

Go deeper on Ileal sodium/bile acid cotransporter (ASBT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ileal sodium/bile acid cotransporter (ASBT).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call